Myelodysplastic syndromes: the complexity of stem-cell diseases (Q36717910)

15 August 2017

1 reference

title

Myelodysplastic syndromes: the complexity of stem-cell diseases (English)

1 reference

15 August 2017

4

Hagop Kantarjian

1 reference

15 August 2017

Seth J Corey

1

1 reference

15 August 2017

Mark D Minden

2

1 reference

15 August 2017

Dwayne L Barber

3

1 reference

15 August 2017

Jean C Y Wang

5

1 reference

15 August 2017

Aaron D Schimmer

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

15 August 2017

Nature Reviews Cancer

1 reference

15 August 2017

7

1 reference

15 August 2017

118-129

1 reference

15 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc2047

15 August 2017

0 references

cites work

Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics

1 reference

Myelodysplastic syndromes: a view from where the sun rises and where the sun sets

31 March 2020

1 reference

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

31 March 2020

1 reference

Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects

31 March 2020

1 reference

Familial partial monosomy 7 and myelodysplasia

31 March 2020

1 reference

Proposals for the classification of the myelodysplastic syndromes

31 March 2020

1 reference

The World Health Organization (WHO) classification of the myeloid neoplasms

31 March 2020

1 reference

The WHO classification of MDS does make a difference

31 March 2020

1 reference

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

31 March 2020

1 reference

Treatment of the 5q- syndrome

31 March 2020

1 reference

Cancer stem cells: lessons from leukemia.

31 March 2020

1 reference

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

31 March 2020

1 reference

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

31 March 2020

1 reference

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.

31 March 2020

1 reference

The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes

31 March 2020

1 reference

Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome

31 March 2020

1 reference

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.

31 March 2020

1 reference

Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes

31 March 2020

1 reference

NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors

31 March 2020

1 reference

Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome

31 March 2020

1 reference

Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID-beta2-microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells

31 March 2020

1 reference

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells

31 March 2020

1 reference

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

31 March 2020

1 reference

EVI1 induces myelodysplastic syndrome in mice

31 March 2020

1 reference

Role of nucleophosmin in embryonic development and tumorigenesis

31 March 2020

1 reference

NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.

31 March 2020

1 reference

Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD(4+) T cells

31 March 2020

1 reference

Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology

31 March 2020

1 reference

Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7.

31 March 2020

1 reference

Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia

31 March 2020

1 reference

Molecular pathogenesis of Fanconi anemia: recent progress

31 March 2020

1 reference

The Fanconi anaemia/BRCA pathway

31 March 2020

1 reference

Ribosomes and marrow failure: coincidental association or molecular paradigm?

31 March 2020

1 reference

The survival kinases Akt and Pim as potential pharmacological targets

31 March 2020

1 reference

Mutations in SBDS are associated with Shwachman-Diamond syndrome

31 March 2020

1 reference

The Shwachman-Bodian-Diamond syndrome gene encodes an RNA-binding protein that localizes to the pseudopod of Dictyostelium amoebae during chemotaxis

31 March 2020

1 reference

The chemotaxis defect of Shwachman-Diamond Syndrome leukocytes

31 March 2020

1 reference

Role of neutrophil elastase in bone marrow failure syndromes: molecular genetic revival of the chalone hypothesis

31 March 2020

1 reference

Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia

31 March 2020

1 reference

Fanconi anaemia syndrome and apoptosis: state of the art.

31 March 2020

1 reference

Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia

31 March 2020

1 reference

Old livers--C/EBPalpha meets new partners

31 March 2020

1 reference

Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway

31 March 2020

1 reference

Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells

31 March 2020

1 reference

Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification

31 March 2020

1 reference

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group

31 March 2020

1 reference

Epipodophyllotoxins in the treatment of childhood cancer

31 March 2020

1 reference

Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group

31 March 2020

1 reference

Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma

31 March 2020

1 reference

Acute myeloid leukemia in a patient with ataxia-telangiectasia: a case report and review of the literature.

31 March 2020

1 reference

Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene

31 March 2020

1 reference

Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia.

31 March 2020

1 reference

Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells

31 March 2020

1 reference

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia

31 March 2020

1 reference

Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia

31 March 2020

1 reference

Human mismatch repair, drug-induced DNA damage, and secondary cancer.

31 March 2020

1 reference

Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation

31 March 2020

1 reference

Defective DNA-mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia.

31 March 2020

1 reference

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

31 March 2020

1 reference

Association of CYP3A4 genotype with treatment-related leukemia

31 March 2020

1 reference

Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis

31 March 2020

1 reference

Biologic characteristics of 164 patients with myelodysplastic syndromes

31 March 2020

1 reference

Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis

31 March 2020

1 reference

Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors

31 March 2020

1 reference

Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome

31 March 2020

1 reference

Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes

31 March 2020

1 reference

Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia

31 March 2020

1 reference

Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes

31 March 2020

1 reference

Myelodysplastic syndrome is not merely "preleukemia"

31 March 2020

1 reference

Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases

31 March 2020

1 reference

Expression and activity of caspases 1 and 3 in myelodysplastic syndromes

31 March 2020

1 reference

Increased caspase-3 activity in refractory anemias: lack of evidence for Fas pathway implication

31 March 2020

1 reference

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.

31 March 2020

1 reference

Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes

31 March 2020

1 reference

Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

31 March 2020

1 reference

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life

31 March 2020

1 reference

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

31 March 2020

1 reference

Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction

31 March 2020

1 reference

Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin

31 March 2020

1 reference

Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines

31 March 2020

1 reference

Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations

31 March 2020

1 reference

Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes.

31 March 2020

1 reference

Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner

31 March 2020

1 reference

Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes

31 March 2020

1 reference

Remicade as TNF suppressor in patients with myelodysplastic syndromes.

31 March 2020

1 reference

Efficacy of lenalidomide in myelodysplastic syndromes

31 March 2020

1 reference

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

31 March 2020

1 reference

Epigenetic therapy of cancer: past, present and future

31 March 2020

1 reference

Myelodysplastic syndromes.

31 March 2020

1 reference

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

31 March 2020

1 reference

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

31 March 2020

1 reference

Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes

31 March 2020

1 reference

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

31 March 2020

1 reference

The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia

31 March 2020

1 reference

Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia

31 March 2020

1 reference

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms

31 March 2020

1 reference

Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome

31 March 2020

1 reference

Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.

31 March 2020

1 reference

A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies.

31 March 2020

1 reference

Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment

31 March 2020

1 reference

Myelodysplastic syndromes

31 March 2020

1 reference

The hematopoietic stem cell in myelodysplasia

31 March 2020

1 reference

Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC2047

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference